(Q34547876)

2 August 2017

1 reference

title

Cationic peptides: effectors in innate immunity and novel antimicrobials (English)

1 reference

2 August 2017

R E Hancock

1

1 reference

2 August 2017

1 October 2001

1 reference

Lancet Infectious Diseases

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

156-164

1 reference

2 August 2017

3

1 reference

Increasing threat of Gram-negative bacteria

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Cationic antimicrobial peptides: towards clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Antimicrobial peptides of vertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Cationic peptides: a new source of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Peptide antibiotics and their role in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

The role of cationic antimicrobial peptides in innate host defences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Synergistic interactions between mammalian antimicrobial defense peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Mutational Analysis of a Plant Defensin from Radish (Raphanus sativusL.) Reveals Two Adjacent Sites Important for Antifungal Activity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

The Cellular Target of Histatin 5 onCandida albicansIs the Energized Mitochondrion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Brugia pahangi: the effects of cecropins on microfilariae in vitro and in Aedes aegypti

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Experimental local therapy of human melanoma with lytic magainin peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Structure-activity analysis of the antitumor and hemolytic properties of the amphiphilic alpha-helical peptide, C18G

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

1 reference

7 January 2021

Action of antimicrobial peptides: two-state model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Magainins as paradigm for the mode of action of pore forming polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Animal antimicrobial peptides: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Production of beta-defensins by human airway epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

The endothelin system in septic and endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

The role of antimicrobial peptides in animal defenses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

A single amino acid substitution in the antimicrobial defense protein cecropin B is associated with diminished degradation by leaf intercellular fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

Chemotactic and protease-inhibiting activities of antibiotic peptide precursors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900092-5

7 January 2021

10.1016/S1473-3099(01)00092-5

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11871492